• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • IBOO 2% for Children
    / Abic


    Active Ingredient
    Ibuprofen 100 mg / 5 ml

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Oral Suspension

    100 ml

    not in the basket chart 24213

    Oral Suspension

    200 ml

    not in the basket chart 23373

    Related information


    Dosage

    The bottle should be shaken before use.
    This medicine is not intended for infants below 3 months of age, or who weigh less than 5 kg. The drug in not intended for prolonged use.
    An additional dose can be taken every 6-8 hours as needed, should not be taken more than 4 times per 24 hours.
    The medicine should be swallowed with water, with or after a meal.
    Extensive fluids intake is necessary under the treatment  in order to prevent dehydration.
    The usual dosage guidelines according to weight of the child:
    5-5.4 (kg):
    2 ml, 3-4 times a day.
    5.5-8.1 (kg): 2.5 ml, 3-4 times a day.
    8.2-10.9 (kg): 3.75 ml, 3-4 times a day.
    11-15 (kg): 5 ml, 3-4 times a day.
    16-21 (kg): 7.5 ml, 3-4 times a day.
    22-26 (kg): 10 ml, 3-4 times a day.
    27-32 (kg): 12.5 ml, 3-4 times a day.
    33-43 (kg): 15 ml, 3-4 times a day.
    Please refer to the license holder for further details.


    Indications

    For the reduction of fever and relief of mild to moderate pain.


    Contra-Indications

    Known hypersensitivity to the active substance or to any of its ingredients.
    3rd trimester  of pregnancy.
    Previous / present known hypersensitivity to aspirin or other NSAIDs (e.g. asthma, runny nose, rash, swelling of the face, tongue, lips or throat, bronchospasm, nasal inflammation).
    Patients with dehydration (serious fluid loss) due to continuous vomiting, diarrhea or lack of fluid intake.
    Patients have suffered in the past, from two or more peptic ulcer episodes, gastro-intestinal perforation or bleeding.
    Patients with history of gastro-intestinal perforation or bleeding due to use of NSAIDs.
    Severe renal, hepatic impairment, heart failure or other cardiac disorders.
    Patients with hematologic disorders.
    Patients with cerebrovascular hemorrhage or from any other hemorrhage.


    Side Effects

    Common side effects (effects that occur in 1-10 in 100 users):
    Heartburn, vomiting, flatulence, nausea, abdominal pain and slight gastrointestinal blood losses, which may, in exceptional cases, cause anemia.
    Diarrhea, flatulence or constipation, dizziness, drowsiness.
    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Pregnancy: Contraindicated in the last three months of pregnancy.
    Lactation: Several studies found very low concentrations of ibuprofen in breast milk; however, it is unlikely that these quantities will have an effect on the baby.
    Please refer to the license holder for further details.


    Manufacturer
    Farmalider S.A., Spain
    Licence holder
    CLOSE